Andere Sprachen Mesoblast Limited Nasdaq

Aktien

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 05.07.2024			% 5 Tage	% 1. Jan.
7,74 ^USD	+13,74 %		+13,66 %	+251,82 %

02.07.	Mesoblast wird einen biologischen Lizenzantrag bei der US FDA für eine zelluläre Therapie einreichen	MT
01.07.	Mesoblast stellt Antrag auf biologische Zulassung für Ryoncil	MT

MESOBLAST TO FILE BIOLOGIC LICENSE APPLICATION FOR RYONCIL FDA APPROVAL NEXT WEEK	02.07.
Mesoblast to File Biological License Application with US FDA for Cellular Therapy	02.07.
Mesoblast to File Biologics License Application for Ryoncil	01.07.
Mesoblast to File Biologics License Application for Ryoncil® FDA Approval Next Week	01.07.
Mesoblast to File Biologics License Application for Ryoncil FDA Approval Next Week	01.07.
Mesoblast Corporate Presentation at Investor Conference	03.06.
Mesoblast Limited Announces Board and Committee Changes	01.05.
Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2024	30.04.
ADRs End Higher; Connect Biopharma Climbs 26%	01.04.
ADRs End Lower; NuCana Slides 15%	28.03.
Reddit Inc. (NYSE: RDDT) Surges, Uncovering Undervalued Opportunities: DYAI, INBS, MESO, VTAK	28.03.
ADRs End Lower; Quhuo Drops 53%	26.03.
FDA Says Mesoblast Trial Data Sufficient to Support BLA Submission	26.03.
Sector Update: Health Care Stocks Advance Late Afternoon	26.03.
Top Midday Gainers	26.03.
Sector Update: Health Care Stocks Steady Premarket Tuesday	26.03.
Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading	26.03.
Top Premarket Gainers	26.03.
Mesoblast Shares Jump After FDA Nod for Submission of Remestemcel-L Application	26.03.
Mesoblast to Resubmit Application for Potential Pediatric Treatment of Graft Versus Host Disease; Shares Gain Pre-Bell	26.03.

Keine Ergebnisse zu dieser Suche